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In recent years, fungal infections have been frequently
encountered in preterm babies, because of the application
of broad-spectrum antibiotics, central venous catheters,
and total parenteral nutrition during long-term hospitali-
zation in neonatal intensive care units (NICUs).1,2 During
the course of fungal infections, fungal endocarditis may
develop in up to 5% of patients, and Candida albicans is
responsible for nearly 50% of them.3 We report a preterm
baby presenting with a giant vegetation of the tricuspid
valve due to C. albicans septicemia, which was refractory
to medical treatment. After the surgical removal of the
vegetation, the patient was successfully weaned off the
antifungal agent 6 weeks later.* Corresponding author. Department of Pediatric Cardiology,
_Istanbul Mehmet Aki fErsoy, Thoracic and Cardiovascular Surgery
Center and Research Hospital, _Istasyon Mahallesi Turgut O¨zal
Bulvarı, Number 11, Ku¨c¸u¨kc¸ekmece, Istanbul, Turkey.
E-mail address: cansaran@yahoo.com (I.C. Tanidir).
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The patient was born at 31 weeks of gestation with a birth
weight of 1100 g via an emergency cesarean section. He
was treated with mechanical ventilation and broad-
spectrum antibiotics in a local hospital, and he was on
partial parenteral nutrition. At the 78th day of birth, he
was referred to our hospital for a new heart murmur and
persistent fever. His weight and length were 1950 g and
42.5 cm, respectively. His general condition was good. A
grade 2/6 systolic murmur was heard over the left lower
sternal border. A two-dimensional echocardiography
revealed a large right atrial mass. The mass was
18 mm  15 mm in size, with an irregular contour and
heterogenous hyperechoic density. This large mass was
found to be oscillating through the tricuspid valve, which
caused partial occlusion of the tricuspid valve in diastole
(Figure 1A and B) and severe tricuspid regurgitation in
systole (Figure 1C). Two sets of blood cultures yielded C.
albicans. Under the diagnosis of candida endocarditis,
enoxaparin (2 mg/kg, q 12 h, subcutaneously) for anti-
coagulation and caspafungin (70 mg/m2/d, intravenously)
for antifungal therapy were started. After 1 week ofy Elsevier Taiwan LLC. All rights reserved.
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remained unchanged in size on the two-dimensional echo-
cardiography. Thus, surgical removal (Figure 1D) was un-
dertaken under cardiopulmonary bypass. The right atrial
mass was resected and the tricuspid valve was repaired. A
histopathological examination of the resected specimen
and culture of the resected vegetation on Sabouraud’s agar
confirmed the diagnosis of infective endocarditis caused by
C. albicans. The antifungal treatment with caspafungin was
continued for 6 weeks. The 8-month follow-up echocardi-
ography showed residual trivial, tricuspid regurgitation.3. Discussion
Fungal infections are frequently encountered in the NICU. A
significant portion of these fungal infections is caused by
the Candida strains. The reported incidence of Candida
infection in NICU is about 1%, but may increase to 4e15% in
extremely low birth weight babies.4 Fungal endocarditis is
an uncommon complication of invasive Candida infection.5
There has been an increased incidence of invasive Candida
infection over the past 15 years.5 Fungal colonization of the
skin and the gastrointestinal tract usually precedes invasive
fungal infection. Colonization is acquired vertically from
maternal vaginal candidiasis or horizontally from caregivers
hand colonization. Some units routinely screen for skin and
rectal colonization of Candida. By reducing colonization,Figure 1 Apical four-chamber view of two-dimensional echocard
to and fro through the tricuspid valve in (A) diastole and (B) systole
mass was shown. * Tricuspid regurgitation. LA Z left atrium; LV Zwe may reduce the incidence of invasive fungal infection
prophylaxis of antifungal agents.5 Risk factors for invasive
candidiasis in the neonatal period include low gestational
age, insertion of central venous catheter, use of broad-
spectrum antibiotics, intubation and mechanical ventila-
tion, and administration of total parenteral nutrition.5 All
these risk factors were present in our patient. Among the
antifungal agents for fungal endocarditis, amphotericin B
has varying degrees of effectiveness in neonates with
Candida infections.6
According to the modified Duke criteria,7 the patient
fulfilled two major criteria (2 sets of positive blood culture
and echocardiographic finding of an oscillating mass) and
one minor criterion (fever > 38C) of infective endocardi-
tis. The patient was diagnosed with fungal endocarditis,
and antifungal treatment was initiated. It is a well-known
fact that penetration of antifungal agents (notably,
amphotericin B) into the infection site is poor, and surgery
is almost always needed in most of the elderly patients. By
contrast, in neonates a consensus for the appropriate
management of fungal endocarditis is lacking.7,8 A combi-
nation of medical and surgical approach has been advo-
cated to treat infants who have ultimately survived Candida
endocarditis.
The general indications for surgery in infective endo-
carditis were stated in previous reports.9 According to
these indications, our patient had “a very large vegetation
(>15 mm),” persistent sepsis (fever or positive bloodiography showed a large right atrial mass was found oscillating
. (C) Severe tricuspid regurgitation. (D) Surgical exposure of the
left ventricle, RA Z right atrium; RV Z right ventricle.
Candida albicans endocarditis 199cultures persisting for >5e7 days), and difficult kind of
organism (fungal). Several factors should be considered in
choosing the treatment modality, including the risk of
perioperative mortality (if surgical intervention is being
considered), the severity of the neonate’s illness, the side
effects of the antifungal treatment, the hemodynamic
status of the patient, and the presence of any blood flow
obstructions.8,9 The optimal timing for the surgery was also
stated previously.9 Patients with large vegetations
(>15 mm) should be operated on urgently (within days),
and those with fungal infections that are resistant to
medical treatment should be operated on during the hos-
pitalization period. In the present case, surgical removal of
the mass was undertaken after consideration of the risks
and unresponsiveness to medical treatment.
In conclusion, surgical removal of giant vegetation of
tricuspid valve endocarditis caused by C. albicans should be
considered as an alternative in preterm babies who react
poorly to antifungal agents.
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